Answers are grounded in this paper and cite their sources.
Recombinant human erythropoietin improved flap survival in ischemia-reperfusion-injured rat TRAM flaps by the possible mechanism of suppressed inflammation, decreased infiltration of neutrophils, increased nitric oxide, and enhanced angiogenesis.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: